v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Deficit Accumulated
Beginning balance (in shares) at Dec. 31, 2023   1,695,788    
Beginning balance at Dec. 31, 2023 $ 26,768 $ 2 $ 192,029 $ (165,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for cash (net of issuance cost) (in shares)   1,663,554    
Issuance of common stock for cash (net of issuance cost) 28,591 $ 1 28,590  
Share-based compensation 5,303   5,303  
Issuance of common stock under equity plan awards (in shares)   23,090    
Issuance of common stock under equity plan award 307   307  
Net loss (41,843)     (41,843)
Ending balance (in shares) at Dec. 31, 2024   3,382,432    
Ending balance at Dec. 31, 2024 19,126 $ 3 226,229 (207,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for cash (net of issuance cost) (in shares)   1,204,774    
Issuance of common stock for cash (net of issuance cost) 6,047 $ 2 6,045  
Share-based compensation 3,118   3,118  
Issuance of pre-funded warrants (net of issuance cost) (in shares)   334,000    
Issuance of pre-funded warrants (net of issuance cost) 3,309   3,309  
Issuance of common stock warrants (net of issuance cost) 1,283   1,283  
Issuance of common stock under equity plan awards (in shares)   5,955    
Issuance of common stock under equity plan award 47   47  
Net loss (26,262)     (26,262)
Ending balance (in shares) at Dec. 31, 2025   4,927,161    
Ending balance at Dec. 31, 2025 $ 6,668 $ 5 $ 240,031 $ (233,368)